Experienced in Diffuse Midline Glioma H3 K27M-Mutant

Dr. Lara K. Ronan

Neurology
1 Medical Center Dr, Dhmc - Dept Of Neurology, 
Lebanon, NH 
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
1 Medical Center Dr, Dhmc - Dept Of Neurology, 
Lebanon, NH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lara Ronan is a Neurologist in Lebanon, New Hampshire. Dr. Ronan is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Astrocytoma, and Glioblastoma.

Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in NH
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1 Medical Center Dr, Dhmc - Dept Of Neurology, Lebanon, NH 03756

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Tissue and Fluid Collection Pilot Study to Develop Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of LM in Patients With Metastatic Solid Tumor Cancer
Tissue and Fluid Collection Pilot Study to Develop Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of LM in Patients With Metastatic Solid Tumor Cancer
Enrollment Status: Completed
Publish Date: August 18, 2020
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

5 Total Publications

A Novel Graphic Medicine Curriculum for Resident Physicians: Boosting Empathy and Communication through Comics.
A Novel Graphic Medicine Curriculum for Resident Physicians: Boosting Empathy and Communication through Comics.
Journal: The Journal of medical humanities
Published: August 19, 2020
Similar Doctors
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Dr. Amandeep Kalra
Neurology | Oncology | Hematology Oncology
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Dr. Amandeep Kalra
Neurology | Oncology | Hematology Oncology

Mary Hitchcock Memorial Hospital

1 Medical Ctr Dr, 
Lebanon, NH 
 (0.2 miles away)
603-650-5000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Amandeep Kalra is a Neurologist and an Oncologist in Lebanon, New Hampshire. Dr. Kalra is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Astrocytoma, Glioblastoma, Oligodendroglioma, and Ependymoma.

Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Dr. Tulika Ranjan
Neurology | Oncology
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Dr. Tulika Ranjan
Neurology | Oncology

Mary Hitchcock Memorial Hospital

1 Medical Ctr Dr, 
Lebanon, NH 
 (0.2 miles away)
603-650-5000
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Tulika Ranjan is a Neurologist and an Oncologist in Lebanon, New Hampshire. Dr. Ranjan is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Ranjan is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ronan's expertise for a condition
ConditionClose
    View All 14 Distinguished Conditions
    View All 49 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile